Erlozest 150mg - Erlotinib Tablets

Price 3500.0 INR/ box

Get a Price/Quote

MOQ : 1 Box

Erlozest 150mg - Erlotinib Tablets Specification

Indication
EGFR-positive Non-Small Cell Lung Cancer (NSCLC) and pancreatic cancer

Origin
india

Dosage Form
Tablets

Salt Composition
Erlotinib Tablets

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
n/a

Temperature Needed For Fermentation
30 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
EGFR Tyrosine Kinase Inhibitor (TKI)

Storage Instructions
Store below 30 C in a cool, dry place; protect from moisture and light

Shelf Life
24 Months

Erlozest 150mg - Erlotinib Tablets Trade Information

Minimum Order Quantity
1 Box

FOB Port
delhi

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Boxes Per Month

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
box

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
n/a

About Erlozest 150mg - Erlotinib Tablets

Erlozest 150 mg Tablet is an anticancer medicine containing the active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.

Inform the doctor if you use contact lenses, have an intolerance to sugars, have a history of eye problems, or if any medicines are taken for clotting disorders or cholesterol. This medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use ofcontact lenses before taking this medication. Erlozest 150 mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose.

Patients are advised not to smoke while being treated with Erlozest 150 mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.